CAMP4 Therapeutics CorporationCAMPNASDAQ
LOADING
|||
Switch Symbol:
EPS Growth Accelerating
Trending higher, above historical average.
Left:
||||
Year-over-year earnings per share growth rate
Latest
11.29%
↑ 219% above average
Average (39q)
-9.52%
Historical baseline
Range
High:2285.43%
Low:-1963.64%
CAGR
+0.3%
Modest growth trend
| Period | Value |
|---|---|
| Q3 2025 | 11.29% |
| Q2 2025 | 3.13% |
| Q1 2025 | 5.88% |
| Q4 2024 | 1.45% |
| Q3 2024 | 13.75% |
| Q2 2024 | 22.33% |
| Q1 2024 | 54.63% |
| Q4 2023 | -1963.64% |
| Q3 2023 | 0.00% |
| Q2 2023 | 50.00% |
| Q1 2023 | -69.23% |
| Q4 2022 | 38.10% |
| Q3 2022 | 38.24% |
| Q2 2022 | -30.77% |
| Q1 2022 | 21.21% |
| Q4 2021 | -120.00% |
| Q3 2021 | -168.34% |
| Q2 2021 | 77.64% |
| Q1 2021 | 64.29% |
| Q4 2020 | -150.00% |
| Q3 2020 | 33.33% |
| Q2 2020 | 74.55% |
| Q1 2020 | -650.00% |
| Q4 2019 | 0.00% |
| Q3 2019 | 15.38% |
| Q2 2019 | -178.79% |
| Q1 2019 | 2285.43% |
| Q4 2018 | 38.37% |
| Q3 2018 | -110.21% |
| Q2 2018 | 284.62% |
| Q1 2018 | -139.39% |
| Q4 2017 | -5.71% |
| Q3 2017 | 562.35% |
| Q2 2017 | 24.30% |
| Q1 2017 | -134.19% |
| Q4 2016 | -398.60% |
| Q3 2016 | 119.72% |
| Q2 2016 | -148.33% |
| Q1 2016 | 36.36% |
| Q4 2015 | 10.00% |